What Is Huntington’S Chorea? The Basics

Huntington’s chorea is an older name for Huntington’s disease, a rare inherited brain disorder that damages nerve cells over time. The word “chorea” comes from the Greek word for dance, and it describes the jerky, involuntary movements that many people with the condition develop. The disease is progressive, meaning symptoms worsen over years, and it affects movement, thinking, and behavior.

Huntington’s disease is caused by a mutation in a single gene called HTT. A person who inherits that mutation will develop the disease at some point in their life. It affects roughly 3 to 7 people per 100,000 of European ancestry, according to data widely cited in neurology literature. It is less common in people of Asian and African ancestry. There is no cure, but the condition and its symptoms can be managed.

What Is Huntington’s Chorea and How Does It Relate to Huntington’s Disease?

Huntington’s chorea and Huntington’s disease are the same condition. “Chorea” was once the primary label because the involuntary movements were the most visible feature. As doctors learned that the disease also causes psychiatric and cognitive decline, the broader term “Huntington’s disease” became standard.

The chorea itself is not random twitching. It is a specific type of involuntary movement that flows from one body part to another, which is why it was compared to dancing. It can look like restlessness, fidgeting, or a continuous stream of unintended motion.

It’s worth knowing that chorea is not the only movement problem in Huntington’s disease. Some people develop rigidity, slowed movement, or problems with balance and coordination instead, particularly when the disease begins in childhood or adolescence. In those cases, chorea may be mild or absent.

What Causes Huntington’s Disease?

Huntington’s disease is caused by a mutation in the HTT gene, which provides instructions for making a protein called huntingtin. The mutation involves a stretch of DNA where three building blocks — cytosine, adenine, and guanine, abbreviated CAG — repeat too many times.

The number of CAG repeats matters. In general:

• Fewer than 27 repeats: the person will not develop Huntington’s disease and cannot pass it on.
• 27 to 35 repeats: the person usually will not develop the disease, but their children may be at risk because the repeat can expand when passed down.
• 36 to 39 repeats: the person may or may not develop symptoms, and children are at risk.
• 40 or more repeats: the person will develop Huntington’s disease if they live long enough, and each child has a 50 percent chance of inheriting it.

These repeat ranges come from established clinical genetics references. A genetic test can measure the exact number.

The mutated gene produces an abnormal form of the huntingtin protein that builds up in brain cells and damages them. The earliest and most severe damage typically occurs in the striatum, a deep brain region involved in movement control and coordination. Over time, damage spreads to other areas, including the cerebral cortex, which helps explain the cognitive and psychiatric symptoms.

How Is Huntington’s Disease Inherited?

Huntington’s disease follows an autosomal dominant pattern. That means a person needs only one copy of the mutated gene to develop the disease. If a parent has it, each child has a 50 percent chance of inheriting the mutation.

If a child does not inherit the mutation, they cannot develop the disease and cannot pass it to their own children. This is a meaningful distinction. Many families assume the risk carries through every generation regardless, but it does not.

One detail that surprises many people: when the gene is passed from father to child, the CAG repeat can expand. This can cause symptoms to appear earlier in the next generation, a pattern called genetic anticipation. It tends to happen more often with paternal transmission.

Symptoms most often begin between ages 30 and 50. When they start before age 20, the condition is called juvenile Huntington’s disease. That form is less common and often looks different, with stiffness, seizures, and declining school performance rather than chorea.

What Are the Symptoms of Huntington’s Disease?

Symptoms fall into three broad categories: movement, thinking, and psychiatric. Not everyone experiences all three, and the order and severity vary from person to person.

Movement symptoms include chorea, problems with voluntary movement, muscle rigidity, slow or abnormal eye movements, and difficulty with speech and swallowing. Walking can become unsteady, and falls become more common as the disease progresses.

Cognitive symptoms include trouble organizing tasks, difficulty learning new information, problems with impulse control, and reduced awareness of one’s own symptoms. This last point matters because a person may not recognize how much the disease is affecting them, which can make caregiving harder.

Psychiatric symptoms include depression, irritability, anxiety, obsessive behavior, and in some cases, hallucinations or delusions. Depression is common and is not simply a reaction to the diagnosis — it appears to be part of how the disease affects the brain.

Early on, symptoms are often subtle. A person might seem more clumsy, forgetful, or irritable. Family members may notice changes before the person does. Because these early signs overlap with many other conditions, diagnosis can take time.

How Is Huntington’s Disease Diagnosed?

Diagnosis usually involves a neurological exam, a review of family history, and genetic testing. The genetic test confirms whether the HTT mutation is present and measures the CAG repeat length.

Imaging such as MRI can show shrinkage in the striatum, but imaging alone cannot confirm the diagnosis. The genetic test is the definitive step.

For people with a known family history, predictive genetic testing is available before symptoms begin. This is a personal decision with significant emotional and practical implications, and clinical guidelines recommend genetic counseling before and after testing. The counseling requirement is not a formality — it helps people understand what a positive or negative result actually means for them and their relatives.

How Is Huntington’s Disease Treated?

There is no treatment that slows or stops the disease. No therapy has been shown in large human trials to change its course. What exists is symptom management.

For chorea specifically, one medication is approved by the U.S. Food and Drug Administration for that purpose. Other medications used to reduce chorea include antipsychotic drugs, though their use for this purpose is based on clinical practice and smaller studies rather than large trials showing meaningful long-term benefit.

Antidepressants and mood stabilizers are commonly used for psychiatric symptoms. Physical therapy, occupational therapy, and speech therapy can help with movement, daily function, and swallowing. Some clinicians recommend these therapies early, before significant decline, though the evidence for how much they change long-term outcomes is limited.

Research into treatments that target the underlying genetic cause is ongoing. Several approaches have been tested in clinical trials, and results so far have not produced an approved disease-modifying therapy. That is the honest state of the field.

What Is the Outlook for Someone With Huntington’s Disease?

Huntington’s disease is progressive and ultimately fatal. Symptoms typically worsen over 10 to 20 years after they begin, though this varies widely. Death is usually caused by complications such as pneumonia, injuries from falls, or infections related to difficulty swallowing.

The rate of progression differs from person to person. Age at onset, the number of CAG repeats, and other factors influence how quickly the disease advances. A younger age at onset generally means faster progression, but this is a broad pattern, not a prediction for any one person.

Care needs increase over time. Most people eventually require full-time help with daily activities, and many need residential or nursing care in the later stages.